Types of cancers |
% of total cancer DALYs |
Types of cancers |
% of
total cancer DALYs |
Types of cancers |
% of total cancer
DALYs |
Stomach cancer |
9·0% |
Breast cancer |
16·8% |
Lung cancer |
10·4% |
Breast cancer |
8·2% |
Cervical cancer |
10·8% |
Lip and oral cavity
cancer |
9·6% |
Lung cancer |
7·5% |
Stomach cancer |
9·0% |
Pharynx cancer other than
nasopharynx |
9·1% |
Lip and oral cavity cancer |
7·2% |
Colon and rectum cancer |
6·1% |
Stomach cancer |
9·0% |
Pharynx cancer other than nasopharynx |
6·8% |
Lip and oral cavity
cancer |
4·6% |
Leukemia |
6·0% |
Colon and rectum cancer |
5·8% |
Ovarian cancer |
4·6% |
Colon and
rectum cancer |
5·6% |
Leukemia |
5·2% |
Lung cancer |
4·4% |
Oesophageal cancer |
5·1% |
Cervical cancer |
5·2% |
Leukemia |
4·3% |
Larynx cancer |
4·8% |
Oesophageal cancer |
4·3% |
Gallbladder and biliary tract cancer |
4·3% |
Liver cancer |
4·6% |
Brain and nervous system cancer |
3·5% |
Pharynx cancer other than
nasopharynx |
4·3% |
Brain and nervous system cancer |
4·0% |
Liver cancer |
3·5% |
Oesophageal cancer |
3·5% |
Non-Hodgkin lymphoma |
3·7% |
Non-Hodgkin lymphoma |
3·2% |
Brain and nervous system cancer |
2·9% |
Prostate cancer |
2·9% |
Gallbladder and biliary tract cancer |
3·1% |
Non-Hodgkin lymphoma |
2·6% |
Pancreatic cancer |
2·6% |
Larynx cancer |
3·0% |
Liver cancer |
2·3% |
Gallbladder and biliary
tract cancer |
2·1% |
Pancreatic cancer |
2·4% |
Pancreatic cancer |
2·2% |
Bladder cancer |
1·5% |
Ovarian cancer |
2·2% |
Uterine cancer |
1·7% |
Nasopharynx cancer |
1·4% |
Prostate cancer |
1·5% |
Thyroid cancer |
1·3% |
Hodgkin’s lymphoma |
1·2% |
Bladder cancer |
1·0% |
Larynx cancer |
1·1% |
Multiple myeloma |
1·0% |
Nasopharynx cancer |
1·0% |
Multiple myeloma |
1·0% |
Kidney cancer |
0·9% |
Multiple myeloma |
1·0% |
Nasopharynx cancer |
0·7% |
Thyroid cancer |
0·7% |
Hodgkin’s lymphoma |
0·9% |
Hodgkin’s lymphoma |
0·6% |
Testicular
cancer |
0·5% |
Uterine cancer |
0·8% |
Bladder cancer |
0·6% |
Mesothelioma |
0·4% |
Kidney cancer |
0·7% |
Kidney cancer |
0·4% |
Breast cancer |
0·3% |
Mesothelioma |
0·3% |
Malignant skin melanoma |
0·2% |
Non-melanoma
skin cancer |
0·3% |
Malignant skin melanoma |
0·3% |
Mesothelioma |
0·2% |
Malignant skin
melanoma |
0·3% |
Testicular cancer |
0·2% |
Non-melanoma skin cancer |
0·1% |
|
|
Non-melanoma skin cancer |
0·2% |
|
|
|
|